Cointime

Nuron Biotech

company

About

Nuron Biotech develops vaccines and specialty biologics for the prevention and treatment of infectious and neurodegenerative diseases.

Highlights

Total Funding Amount
$102.70M
Funding Rounds
2
Investors
1
Employee Profiles
1

Details

Last Funding Type
Private Equity（PE）
Last Funding Money Raised
$22.70M
Industries
Biotechnology,Health Care,Medical
Founded date
Jan 1, 2010
Number Of Employee
11 - 50
Operating Status
Active

Nuron Biotech Inc. develops specialty biologics and vaccines. Its product pipeline comprises central nervous system products, such as NU100, a recombinant human interferon beta-1b for the treatment of relapsing remitting multiple sclerosis; wound healing products, including NU200, a recombinant human epidermal growth factor product for healing diabetic foot ulcers and burns; and HibTITER, a conjugate vaccine. The company was founded in 2010 and is based in Exton, Pennsylvania.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$102.70M
Nuron Biotech has raised a total of $102.70M in funding over 2 rounds. Their latest funding was raised on Feb 12, 2014 from a Private Equity（PE） round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 12, 2014 Private Equity（PE） $22.70M 1 — — Detail
Dec 26, 2012 Private Equity（PE） $80M 1 HealthCare Royalty Partners — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Nuron Biotech is funded by 1 investors. HealthCare Royalty Partners are the most recent investors.
Investor Name Lead Investor Funding Round
HealthCare Royalty Partners — Private Equity（PE）

Employee Profiles

Number of Employee Profiles
1
Nuron Biotech has 1 current employee profiles, including Board member Gregory B. Brown, MD
Gregory B. Brown, MD
Board member
Cointime
Content
Company